Sign up to our news­letter

Do you want to know more about Kale Growth or the opportunities to invest in Kale United? We bring you updates on our portfolio companies in the agrifoodtech space.

I want to subscribe to the newsletter and accept the privacy policy

The challenge

Chronic lifestyle diseases place a significant burden on healthcare systems worldwide, causing significant costs and suffering. A global shift toward a plant-based food system could play a critical role in reducing the burden of these diseases.

Cardiovascular diseases (CVD) are a major burden on global healthcare, incurring over $1 trillion USD annually and causing significant human suffering. CVD alone accounts for 32% of global deaths, yet 57% of critical illnesses could be avoided with dietary changes. 

Food as medicine

Studies show that a plant-based diet lowers the risk of CVD mortality by 25%. Adopting a plant-based food system presents a powerful opportunity to ease this burden on healthcare systems worldwide and save lives. Potential savings in CVD health care costs are $250 billion USD. And at the same time reduce cause of death globally by 8%. 


The opportunity

International investment banks are now calculating the market potential for fast-growing protein alternatives. Barclays expects the market for plant-based meat products to grow tenfold over the next ten years, while UBS expects growth of 30 per cent annually until 2025.

Our commitment

Kale United’s holdings are positioned to accelerate the migration to a more plant-based lifestyle. The effect on human health is measured and disclosed for all our assets.